AU2004278517B2 - Packaging cells for recombinant adenovirus - Google Patents

Packaging cells for recombinant adenovirus Download PDF

Info

Publication number
AU2004278517B2
AU2004278517B2 AU2004278517A AU2004278517A AU2004278517B2 AU 2004278517 B2 AU2004278517 B2 AU 2004278517B2 AU 2004278517 A AU2004278517 A AU 2004278517A AU 2004278517 A AU2004278517 A AU 2004278517A AU 2004278517 B2 AU2004278517 B2 AU 2004278517B2
Authority
AU
Australia
Prior art keywords
nucleic acid
ela
elb
sequences
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004278517A
Other languages
English (en)
Other versions
AU2004278517A1 (en
Inventor
Menzo Jans Emco Havenga
Ronald Vogels
David A.T.M. Zuijdgeest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Vaccines and Prevention BV
Original Assignee
Crucell Holand BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holand BV filed Critical Crucell Holand BV
Publication of AU2004278517A1 publication Critical patent/AU2004278517A1/en
Application granted granted Critical
Publication of AU2004278517B2 publication Critical patent/AU2004278517B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/38—Vector systems having a special element relevant for transcription being a stuffer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2004278517A 2003-10-02 2004-10-04 Packaging cells for recombinant adenovirus Ceased AU2004278517B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP0350679 2003-10-02
AU2003298262 2003-10-02
PCT/EP2004/052428 WO2005033320A1 (en) 2003-10-02 2004-10-04 Packaging cells for recombinant adenovirus

Publications (2)

Publication Number Publication Date
AU2004278517A1 AU2004278517A1 (en) 2005-04-14
AU2004278517B2 true AU2004278517B2 (en) 2010-04-01

Family

ID=34400432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004278517A Ceased AU2004278517B2 (en) 2003-10-02 2004-10-04 Packaging cells for recombinant adenovirus

Country Status (15)

Country Link
US (2) US7816104B2 (enExample)
EP (1) EP1670925B1 (enExample)
JP (1) JP4749334B2 (enExample)
KR (1) KR101203817B1 (enExample)
CN (2) CN1863918B (enExample)
AU (1) AU2004278517B2 (enExample)
BR (1) BRPI0414670A (enExample)
CA (1) CA2538025C (enExample)
DK (1) DK1670925T3 (enExample)
EA (1) EA010924B1 (enExample)
HR (1) HRP20130616T1 (enExample)
IL (2) IL174489A (enExample)
NZ (1) NZ545501A (enExample)
SI (1) SI1670925T1 (enExample)
WO (1) WO2005033320A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
EP1670925B1 (en) 2003-10-02 2013-05-01 Crucell Holland B.V. Packaging cells for recombinant adenovirus
EP1998804B1 (en) * 2006-03-27 2014-04-16 Crucell Holland B.V. Compositions comprising a recombinant adenovirus and an adjuvant
WO2008134720A2 (en) * 2007-04-30 2008-11-06 Medtronic, Inc. Inert dna sequences for efficient viral packaging and methods of use
CA2742474C (en) 2008-11-03 2016-05-31 Crucell Holland B.V. Method for the production of adenoviral vectors
KR101427200B1 (ko) * 2011-11-24 2014-08-07 주식회사 바이로메드 아데노바이러스 생산 신규 세포주 및 그의 용도
MY170927A (en) 2011-11-28 2019-09-19 Janssen Vaccines & Prevention Bv Influenza virus vaccines and uses thereof
AP2014007993A0 (en) * 2012-03-22 2014-10-31 Crucell Holland Bv Vaccine against RSV
CN110832072B (zh) 2017-04-21 2023-11-07 真基因太科公司 用于生产非复制型腺病毒的细胞系以及制备所述细胞系的方法
CN108342362A (zh) * 2018-01-31 2018-07-31 武汉枢密脑科学技术有限公司 一种用于扩增重组犬腺病毒cav2的稳定细胞系mdck及其构建方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040665A2 (en) * 2000-11-15 2002-05-23 Crucell Holland B.V. Complementing cell lines
WO2003031633A2 (de) * 2001-10-04 2003-04-17 Probiogen Ag Adenovirales vektorsystem

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889806A (en) * 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5834256A (en) 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
US5820868A (en) 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
WO1995034671A1 (en) 1994-06-10 1995-12-21 Genvec, Inc. Complementary adenoviral vector systems and cell lines
FI972225A7 (fi) 1994-11-28 1997-07-16 Genetic Therapy Inc Vektorit kudosspesifistä replikaatiota varten
CA2206683A1 (en) 1994-12-12 1996-06-20 Genetic Therapy, Inc. Improved adenoviral vectors and producer cells
EP1445322B2 (en) * 1995-06-15 2012-06-06 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
ATE289354T1 (de) 1999-04-15 2005-03-15 Crucell Holland Bv Verwendung von adenovirus e1 protein sequenzen kodierenden, zur herstellung von rekombinanten proteinen in menschlichen zellen.
US6558948B1 (en) 1999-11-23 2003-05-06 Stefan Kochanek Permanent amniocytic cell line, its production and use for the production of gene transfer vectors
EP1103610A1 (en) 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
CA2812799C (en) 2001-07-04 2016-01-26 Chromagenics B.V. Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
US7026164B2 (en) 2003-07-03 2006-04-11 Cell Genesys, Inc. Adenovirus packaging cell lines
EP1670925B1 (en) 2003-10-02 2013-05-01 Crucell Holland B.V. Packaging cells for recombinant adenovirus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040665A2 (en) * 2000-11-15 2002-05-23 Crucell Holland B.V. Complementing cell lines
WO2003031633A2 (de) * 2001-10-04 2003-04-17 Probiogen Ag Adenovirales vektorsystem

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VAN DEN ELSEN et al. (1982) Gene, vol. 18(2), pages 175-186 *

Also Published As

Publication number Publication date
US20100311172A1 (en) 2010-12-09
IL174489A (en) 2013-10-31
CN102174536B (zh) 2013-02-13
CN1863918A (zh) 2006-11-15
AU2004278517A1 (en) 2005-04-14
HRP20130616T1 (en) 2013-08-31
CN102174536A (zh) 2011-09-07
BRPI0414670A (pt) 2006-11-21
CN1863918B (zh) 2011-03-30
US20060183232A1 (en) 2006-08-17
IL227543A (en) 2015-08-31
HK1084974A1 (en) 2006-08-11
KR20060095557A (ko) 2006-08-31
CA2538025A1 (en) 2005-04-14
IL174489A0 (en) 2006-08-01
EP1670925A1 (en) 2006-06-21
KR101203817B1 (ko) 2012-11-23
DK1670925T3 (da) 2013-07-08
EP1670925B1 (en) 2013-05-01
US8114637B2 (en) 2012-02-14
SI1670925T1 (sl) 2013-10-30
NZ545501A (en) 2010-12-24
JP4749334B2 (ja) 2011-08-17
WO2005033320A1 (en) 2005-04-14
CA2538025C (en) 2012-07-17
EA010924B1 (ru) 2008-12-30
US7816104B2 (en) 2010-10-19
EA200600693A1 (ru) 2006-10-27
JP2007507216A (ja) 2007-03-29

Similar Documents

Publication Publication Date Title
JP4402881B2 (ja) 相補細胞株
US8114637B2 (en) Packaging cells for recombinant adenovirus
US5286636A (en) DNA cloning vectors with in vivo excisable plasmids
CN112921054B (zh) 一种用于治疗β-地中海贫血的慢病毒载体及其制备方法和应用
CN112813038A (zh) 一株表达asfv结构囊膜蛋白的prrs病毒及其构建方法与应用
CN113755442B (zh) 一种用于药物活性测定的细胞株及其制备方法与应用
CN104962576B (zh) 一种柱状黄杆菌基因定向敲除质粒及应用
CN111235118B (zh) 一种人3型腺病毒复制缺陷型重组病毒、构建方法及应用
CN110272917B (zh) 一套快速准确的三质粒溶瘤腺病毒重组包装系统Ad5MixPlus及其应用
WO1996009399A2 (en) Chimeric adenovirus for gene delivery
CN112760342B (zh) 一种用于glp-1及其类似物活性测定的慢病毒载体及细胞株
CN110117622B (zh) 一种CRISPR/Cas基因编辑系统及其制备方法和应用
CN110331170A (zh) 一种双重gRNA的基因表达元件及其构建方法与应用
CN107267538B (zh) 一种植物质体表达载体的构建方法及应用
CN110452893B (zh) 一种高保真CRISPR/AsCpf1突变体的构建及其应用
CN111041027B (zh) 一种Atg12基因敲除细胞系构建方法及其应用
CN116064657B (zh) 一种腺嘌呤碱基编辑工具及其方法和应用
CN109777829A (zh) 一种基因编辑U6启动子驱动的sgRNA表达组件的构建方法
CN110055280A (zh) 一种稳定表达mCherry-tau的细胞系及其构建方法与应用
CN107400678A (zh) 一种用于高效纯化相互作用蛋白的克隆载体
CN106591369A (zh) 一种应用腺病毒系统靶向编辑水牛18S rDNA基因的方法
CN114836391A (zh) 一种重组t4噬菌体及其在制备流感病毒鼻内递送vlp疫苗中的应用
CN117264902A (zh) 一种腺病毒包装与生产细胞系的构建方法及应用
White The establishment of two novel bovine cell lines by transfection with the putative transforming region of bovine adenovirus type 3
HK1084974B (en) Packaging cells for recombinant adenovirus

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired